Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Potomac Health News.
FDA Veteran Tom Sundlof Joins Blank Rome as Partner in Washington, D.C., Strengthening National Life Sciences Team
Washington, D.C., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Blank Rome LLP is pleased to announce that Tom Sundlof, former senior attorney at the U.S. Food and Drug Administration (“FDA”), has joined the firm’s Washington, D.C., office as a partner in the...
Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule...
EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients
Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeks Good tolerability with no systemic side effects First DNA medicine to selectively target, at the local level, a specific subtype of sensory neurons Fully...
Animal Wellness Action and the Center for a Humane Economy Mourn the Passing of Dr. Jane Goodall
WASHINGTON, DC, UNITED STATES, October 1, 2025 /EINPresswire.com/ -- Today, Animal Wellness Action and the Center for a Humane Economy expressed deep sadness over the loss of one of history’s greatest moral voices for animals. Dr. Jane Goodall...
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SARASOTA, FL, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional...
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary...
State mental health rankings released: New York and Hawaii rank highest, Nevada and Arizona rank lowest
ALEXANDRIA, Va., Oct. 01, 2025 (GLOBE NEWSWIRE) -- New York, Hawaii, and New Jersey ranked best in the nation across common measures of mental health in 2022 and 2023, according to the latest State of Mental Health in America report from Mental...
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan Club, New...
Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting
The approach defies the restrictive weight loss paradigm, with early results indicating increased meal tracking and member engagement1 with new real-time, personalized nutrition guidance SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Omada...
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH Dr. Arbet-Engels has led late-stage development, regulatory approvals and commercial launches for multiple successful franchises GAITHERSBURG, Md., Sept. 29, 2025...
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68 plan options across 45 counties in five states....
Orthopedic Devices Market Size Expected to Reach USD 96.45 Billion by 2034
Ottawa, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The global orthopedic devices market size was valued at USD 63.06 billion in 2024 and is predicted to hit around USD 96.45 billion by 2034, rising at a 4.34% CAGR, a study published by Towards Healthcare a...
Ralph A. DeFronzo, M.D. - 716773 - 09/17/2025
Delivery Method: VIA UNITED PARCEL SERVICE AND VIA E-MAIL Reference #: 25-HFD-45-09-02 Product: Drugs Recipient: Recipient Name Ralph A. DeFronzo, M.D. Recipient Title Department of Medicine, Diabetes Division Ralph A. DeFronzo, M.D. 7703 Floyd...
Owner: American Government
Advanced Muscle Integration Technique (AMIT®) Expands the Future of Orthopedic and Sports Medicine
A.M.I.T.® offers a cutting-edge approach to muscle dysfunction, helping active individuals recover faster and move better using nontraditional methods. DRAPER, UT, UNITED STATES, September 30, 2025 /EINPresswire.com/ -- A new era in sports...
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SARASOTA, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional...
Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Fluor Corporation (NYSE: FLR); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating…
PHILADELPHIA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): Grabar Law Office is investigating whether certain officers and directors of DoubleVerify Holdings, Inc. (NYSE: DV) breached their fiduciary duties owed to...
Special Investigating Unit releases interim report on Tembisa Hospital investigation
#Tembisahospitalcapture: How two billion meant for healthcare was stolen The Special Investigating Unit (SIU) can reveal that there is a devastating plunder of the public purse, which we found in our probe into Tembisa Hospital, uncovering three...
Owner: South African Government
Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026
Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 granted Orphan Drug and Rare Pediatric Disease...
Health Professionals Support the Direct Surrender Method as Compassionate and Humane
A Safe Haven for Newborns’ Partnership with Hospitals and Fire/EMS is Saving Lives MIAMI, FL, UNITED STATES, September 25, 2025 /EINPresswire.com/ -- The Gloria M. Silverio Foundation, 501 (C) 3, d/b/a A Safe Haven for Newborns, was founded in...
Vancouver’s Finest: MICHELIN Guide 2025 selection revealed
VANCOUVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Sumibiyaki Arashi and Sushi Hyun receive a MICHELIN Star, bringing city’s total to 12 New Bib Gourmand added, plus four Special Awards 76 total restaurants, 22 cuisine types reflected in the city Guide...